High-Dose Ifosfamide as Second- or Third-Line Chemotherapy in Refractory Bone and Soft Tissue Sarcoma Patients

Publisher： Karger

E-ISSN： 1423-0232|80|3-4|257-261

ISSN： 0030-2414

Source： Oncology, Vol.80, Iss.3-4, 2011-07, pp. : 257-261

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Is There an Indication for High-Dose Chemotherapy in the Treatment of Bone and Soft-Tissue Sarcoma?

By  

Oncology, Vol. 68, Iss. 2-3, 2005-07 ,pp. : 115-121

Karger

Access to resources Recommend Favorite

Efficacy of Consolidation High-Dose Chemotherapy with Ifosfamide, Carboplatin and Etoposide (HD-ICE) Followed by Autologous Peripheral Blood Stem Cell Rescue in Chemosensitive Patients with Metastatic Soft Tissue Sarcomas

By  

Oncology, Vol. 71, Iss. 1-2, 2007-04 ,pp. : 32-39

Karger

Access to resources Recommend Favorite

Chemotherapy for soft tissue sarcoma

By  

CANCER, Vol. 122, Iss. 19, 2016-10 ,pp. : 2952-2960

John Wiley & Sons Inc

Access to resources Recommend Favorite

Anthracycline-induced cardiotoxicity in patients with paediatric bone sarcoma and soft tissue sarcoma

By  

Cardiology in the Young, Vol. 27, Iss. 9, 2017-08 ,pp. : 1815-1822

Cambridge University Press

Access to resources Recommend Favorite

Ifosfamide dose‐intensification for patients with metastatic Ewing sarcoma

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 4, 2015-04 ,pp. : 594-597

John Wiley & Sons Inc

Access to resources Recommend Favorite